Massachusetts Financial Services
NVAX icon

Massachusetts Financial Services’s Novavax NVAX Stock Holding History

Massachusetts Financial Services’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Sell
161,156
-3,397
-2% -$30.4K ﹤0.01% 853
2026
Q1 		$1.34M Sell
164,553
-34,553
-17% -$313K ﹤0.01% 825
2025
Q4 		$1.34M Buy
199,106
+102,945
+107% +$776K ﹤0.01% 818
2025
Q3 		$834K Buy
96,161
+6,324
+7% +$49.2K ﹤0.01% 809
2025
Q2 		$566K Buy
89,837
+1,109
+1% +$7.34K ﹤0.01% 842
2025
Q1 		$569K Sell
88,728
-2,020
-2% -$16.7K ﹤0.01% 841
2024
Q4 		$730K Sell
90,748
-2,709
-3% -$26.1K ﹤0.01% 829
2024
Q3 		$1.18M Buy
93,457
+18,229
+24% +$235K ﹤0.01% 785
2024
Q2 		$952K Buy
+75,228
New +$757K ﹤0.01% 801
2023
Q2 		– Sell
-18,120
Closed -$126K – 860
2023
Q1 		$126K Sell
18,120
-515
-3% -$4.74K ﹤0.01% 838
2022
Q4 		$192K Buy
18,635
+395
+2% +$6.97K ﹤0.01% 843
2022
Q3 		$332K Sell
18,240
-166
-0.9% -$7.19K ﹤0.01% 827
2022
Q2 		$947K Buy
18,406
+9,606
+109% +$498K ﹤0.01% 775
2022
Q1 		$648K Buy
+8,800
New +$785K ﹤0.01% 817
2021
Q4 		– Sell
-4,734
Closed -$981K – 926
2021
Q3 		$981K Sell
4,734
-4,607
-49% -$1.02M ﹤0.01% 833
2021
Q2 		$1.98M Sell
9,341
-8,087
-46% -$1.48M ﹤0.01% 782
2021
Q1 		$3.16M Sell
17,428
-2,106
-11% -$420K ﹤0.01% 723
2020
Q4 		$2.18M Sell
19,534
-198
-1% -$21K ﹤0.01% 726
2020
Q3 		$2.14M Buy
+19,732
New +$2.4M ﹤0.01% 708
2016
Q3 		– Sell
-41,173
Closed -$5.99M – 873
2016
Q2 		$5.99M Buy
41,173
+9,473
+30% +$1.09M ﹤0.01% 627
2016
Q1 		$3.27M Buy
31,700
+393
+1% +$42.2K ﹤0.01% 680
2015
Q4 		$5.25M Sell
31,307
-214
-0.7% -$32.9K ﹤0.01% 646
2015
Q3 		$4.46M Sell
31,521
-690
-2% -$155K ﹤0.01% 678
2015
Q2 		$7.18M Sell
32,211
-16,654
-34% -$2.93M ﹤0.01% 636
2015
Q1 		$8.08M Buy
48,865
+1,498
+3% +$243K ﹤0.01% 631
2014
Q4 		$5.62M Buy
+47,367
New +$4.95M ﹤0.01% 657

Other funds holding NVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Massachusetts Financial Services's NVAX Position: Q2 2026 in Review

Massachusetts Financial Services reduced its Novavax (NVAX) stake by 2.1% in Q2 2026, selling an estimated $30.4K and leaving 161,156 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #853.

Massachusetts Financial Services first reported a position in NVAX in Q4 2014 and has held it in 26 quarters since. The position peaked at $8.08M in Q1 2015. 104 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Massachusetts Financial Services held 161,156 shares of Novavax worth $1.52M as of Q2 2026.
  • Massachusetts Financial Services sold 3,397 Novavax shares in Q2 2026, an estimated $30.4K.
  • Novavax made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #853 holding.
  • Massachusetts Financial Services first reported a position in Novavax in Q4 2014 and has held it in 26 quarters since.
  • Massachusetts Financial Services's Novavax position peaked at $8.08M in Q1 2015.
  • 104 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.